SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

Stoke Therapeutics Q1 EPS $(0.340) Up From $(6.890) YoY

Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(0.340) per share. This is a 95.07 percent increase over losses of $(6.890) per share from the same period last year.

Benzinga · 05/15/2020 11:03

Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(0.340) per share. This is a 95.07 percent increase over losses of $(6.890) per share from the same period last year.